Pharming Group N.V.

PHGUF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$8-$10$15$22
Dep. & Amort.$16$16$13$19
Deferred Tax$0$0$0-$1
Stock-Based Comp.$11$9$6$9
Change in WC-$10-$17-$0-$5
Other Non-Cash-$11-$16-$11-$8
Operating Cash Flow-$2-$17$23$36
Investing Activities
PP&E Inv.-$1-$1-$2-$16
Net Acquisitions$0$0$7$0
Inv. Purchases-$284-$382$0-$4
Inv. Sales/Matur.$317$233$0$0
Other Inv. Act.-$0$21$6-$0
Investing Cash Flow$32-$129$5-$20
Financing Activities
Debt Repay.-$34-$5-$3-$3
Stock Issued$5$0$2$5
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$5$4-$4-$30
Financing Cash Flow-$34-$1-$5-$27
Forex Effect-$2$2-$8$13
Net Chg. in Cash-$7-$146$15$3
Supplemental Information
Beg. Cash$62$207$192$189
End Cash$55$62$207$192
Free Cash Flow-$7-$19$21$20